Arno Kromminga

Company: IPM Biotech

PD Dr. Arno Kromminga is founder and CEO/CSO of GLP-certified IPM BIOTECH, is heading the Immunology at the Clinical Laboratory Lademannbogen in Hamburg, Germany, and has a position at the University of Kiel, Germany. He studied biochemistry and immunology and has 15+ year experience in assay development and is author of multiple publications in peer-reviewed journals and books. He is cofounder of the European Immunogenicity Platform (EIP). He gained substantial industrial experience in various biotech companies. He has been involved in the development and establishment of novel immunological and cellular assays for immunogenicity testing and PK/PD analysis for pre-clinical and clinical studies in compliance with GLP regulation. Most importantly he aims to interpret ADA, PK/PD data in the context of clinical consequences and manifestations.